AI and Nanomedicine Breakthrough: Detecting Rare Biomarkers for Prostate Cancer and Atherosclerosis
Researchers from Michigan State University and partners have developed a novel method combining nanomedicine, AI, and causal analysis to identify rare biomarkers for metastatic prostate cancer and atherosclerosis, potentially revolutionizing early disease detection and personalized treatment.